(Q48301302)

10 February 2018

title

Neuropsychological test performance, brain morphological measures and CSF monoamine metabolites in schizophrenic patients (English)

1 reference

10 February 2018

0 references

1 reference

Nyman H

1

1 reference

10 February 2018

Nybäck H

2

1 reference

10 February 2018

Wiesel FA

3

1 reference

10 February 2018

Oxenstierna G

4

1 reference

10 February 2018

Schalling D

5

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 September 1986

1 reference

10 February 2018

Acta Psychiatrica Scandinavica

published in

1 reference

10 February 2018

volume

74

1 reference

10 February 2018

issue

3

1 reference

10 February 2018

page(s)

292-301

1 reference

10 February 2018

Neuropathological Studies of Schizophrenia: A Selective Review

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1986.TB06246.X

Cerebral ventricular size and cognitive impairment in chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1986.TB06246.X

Lateral Cerebral Ventricular Enlargement in Chronic Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1986.TB06246.X

The dopamine hypothesis: an overview of studies with schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1986.TB06246.X

Cerebroventricular size and cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1986.TB06246.X

Bimodal Distribution of Dopamine Receptor Densities in Brains of Schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1986.TB06246.X

Cerebral ventricular size and neuropsychological impairment in young chronic schizophrenics. Measurement by the standardized Luria-Nebraska Neuropsychological Battery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1986.TB06246.X

Bilateral skin conductance activity, clinical symptoms and CSF monoamine metabolite levels in unmedicated schizophrenics, differing in rate of habituation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1986.TB06246.X

Simultaneous determination of the three major monoamine metabolites in brain tissue and body fluids by a mass fragmentographic method

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1986.TB06246.X

Effects of sulpiride and chlorpromazine on autistic and positive psychotic symptoms in schizophrenic patients--relationship to drug concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1986.TB06246.X

Smooth pursuit eye tracking, neuropsychological test performance, and computed tomography in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1986.TB06246.X

Regional cortical dysfunction in schizophrenic patients studied by computerized neuropsychological methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1986.TB06246.X

Atrophy limited to the third ventricle in chronic schizophrenic patients. Report of a controlled series

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1986.TB06246.X

Ventricular enlargement in schizophrenia: relationship to positive and negative symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1986.TB06246.X

Dopamine-beta-hydroxylase activity and homovanillic acid in spinal fluid of schizophrenics with brain atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1986.TB06246.X

10.1111/J.1600-0447.1986.TB06246.X

21 January 2018

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018